{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:45:27Z","timestamp":1700750727397},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00105-020-04715-y","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T15:02:41Z","timestamp":1605625361000},"page":"932-943","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapie von Pigmentst\u00f6rungen in Zusammenhang mit systemischen Erkrankungen","Treatment of pigmentation disorders in association with systemic diseases"],"prefix":"10.1007","volume":"71","author":[{"given":"Sorina","family":"Danescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Salavastru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GS","family":"Tiplica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"issue":"1","key":"4715_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/lsm.22443","volume":"48","author":"J Chun-Yin Chan","year":"2016","unstructured":"Chun-Yin Chan\u00a0J, Yee-nam Shek\u00a0S, Kono\u00a0T, Keung Yeung\u00a0C, Hin-lee Chan\u00a0H (2016) A retrospective analysis on the management of pigmented lesions using a\u00a0picosecond 755-nm alexandrite laser in Asians. Lasers Surg Med 48(1):23\u201329","journal-title":"Lasers Surg Med"},{"issue":"8","key":"4715_CR2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10103-018-2459-z","volume":"33","author":"A Alegre-Sanche","year":"2018","unstructured":"Alegre-Sanche\u00a0A (2018) Treatment of flat and elevated pigmented disorders with a\u00a0755-nmalexandrite picosecond laser: clinical and histological evaluation. Lasers Med Sci 33(8):1827\u20131831","journal-title":"Lasers Med Sci"},{"issue":"2","key":"4715_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lsm.22454","volume":"48","author":"M Kanchanapoomi Levin","year":"2016","unstructured":"Kanchanapoomi Levin\u00a0M, Ng\u00a0E, Bae\u00a0Y\u2011SC, Brauer\u00a0JA, Geronemus\u00a0RG (2016) Treatment of pigmentary disorders in patients with skin of color with a\u00a0novel 755\u202fnm picosecond, Q\u2011switched ruby, and Q\u2011switched Nd:YAG nanosecond lasers: a retrospective photographic review. Lasers Surg Med 48(2):181\u2013187","journal-title":"Lasers Surg Med"},{"issue":"1","key":"4715_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lsm.22433","volume":"48","author":"Y Tanaka","year":"2016","unstructured":"Tanaka\u00a0Y, Tsunemi\u00a0Y, Kawashima\u00a0M (2016) Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635\u202fnm. Lasers Surg Med 48(1):30\u201335","journal-title":"Lasers Surg Med"},{"issue":"9","key":"4715_CR5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s10103-018-2560-3","volume":"33","author":"V Vachiramon","year":"2018","unstructured":"Vachiramon\u00a0V, Iamsumang\u00a0W, Triyangkulsri\u00a0K (2018) Q\u2011switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians. Lasers Med Sci 33(9):1941\u20131947","journal-title":"Lasers Med Sci"},{"key":"4715_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/lsm.22472","volume":"48","author":"V Vachiramon","year":"2016","unstructured":"Vachiramon\u00a0V, Panmanee\u00a0W, Techapichetvanich\u00a0T, Chanprapaph\u00a0K (2016) Comparison of Q\u2011switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentiginesin asians. Lasers Surg Med 48:354\u2013359","journal-title":"Lasers Surg Med"},{"issue":"8","key":"4715_CR7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/lsm.22820","volume":"50","author":"K Negishi","year":"2018","unstructured":"Negishi\u00a0K, Akita\u00a0H, Matsunaga\u00a0Y (2018) Prospective study of removing solar lentigines in asiansusing a\u00a0novel dual-wavelength and dual-pulse width picosecond laser. Lasers Surg Med 50(8):851\u2013858","journal-title":"Lasers Surg Med"},{"issue":"9","key":"4715_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lsm.23103","volume":"51","author":"MWM Chan","year":"2019","unstructured":"Chan\u00a0MWM, Yee-Nam Shek\u00a0S, Keung Yeung\u00a0C, Hin-Lee Chan\u00a0H (2019) A prospective study in the treatment of lentigines in asian skin using 532\u202fnm picosecond Nd:YAG laser. Lasers Surg Med 51(9):767\u2013773","journal-title":"Lasers Surg Med"},{"key":"4715_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23244","author":"DC Wu","year":"2020","unstructured":"Wu\u00a0DC, Goldman\u00a0MP, Wat\u00a0H, Chan\u00a0HHL (2020) A systematic review of picosecond laser in dermatology: evidence and recommendations. Lasers Surg Med. https:\/\/doi.org\/10.1002\/lsm.23244","journal-title":"Lasers Surg Med"},{"key":"4715_CR10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/000155599750010067","volume":"79","author":"CC Zouboulis","year":"1999","unstructured":"Zouboulis\u00a0CC, Rosenberger\u00a0AD, Adler\u00a0Y, Orfanos\u00a0CE (1999) Treatment of solar lentigo with cryosurgery. Acta Derm Venereol 79:489\u2013490","journal-title":"Acta Derm Venereol"},{"key":"4715_CR11","first-page":"352","volume":"29","author":"C Cotellessa","year":"2003","unstructured":"Cotellessa\u00a0C, Peris\u00a0K, Fargnoli\u00a0MC, Mordenti\u00a0C, Giacomello\u00a0RS, Chimenti\u00a0S (2003) Microabrasion versus microabrasion followedby 15\u202f% trichloroacetic acid for treatment of cutaneoushyperpigmentation in adult females. Dermatol Surg 29:352\u2013356","journal-title":"Dermatol Surg"},{"key":"4715_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1046\/j.1365-4362.2003.01951.x","volume":"42","author":"A Lugo-Janer","year":"2003","unstructured":"Lugo-Janer\u00a0A, Lugo-Somolinos\u00a0A, Sanchez\u00a0JL (2003) Comparison of trichloroacetic acid solution and cryosurgery in the treatment of solar lentigines. Int J Dermatol 42:829\u2013831","journal-title":"Int J Dermatol"},{"key":"4715_CR13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2005.12.043","volume":"54","author":"J-P Ortonne","year":"2006","unstructured":"Ortonne\u00a0J\u2011P, Pandya\u00a0AG, Lui\u00a0H, Hexsel\u00a0D (2006) Treatment of solar lentigines. J\u00a0Am Acad Dermatol 54:262\u2013271","journal-title":"J Am Acad Dermatol"},{"key":"4715_CR14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1468-3083.2003.00808.x","volume":"17","author":"L Petit","year":"2003","unstructured":"Petit\u00a0L, Pierard\u00a0GE (2003) Analytic quantification of solar lentigineslightening by a\u00a02\u202f% hydroquinone-cyclodextrin formulation. J\u00a0Eur Acad Dermatol Venereol 17:546\u2013549","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4715_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.1991.01680040067005","volume":"127","author":"GD Weinstein","year":"1991","unstructured":"Weinstein\u00a0GD, Nigra\u00a0TP, Pochi\u00a0PE, Savin\u00a0RC, Allan\u00a0A, Benik\u00a0K et\u00a0al (1991) Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol 127:659\u2013665","journal-title":"Arch Dermatol"},{"key":"4715_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2003.451","volume":"49","author":"S Kang","year":"2003","unstructured":"Kang\u00a0S, Goldfarb\u00a0MT, Weiss\u00a0JS, Metz\u00a0RD, Hamilton\u00a0TA, Voorhees\u00a0JJ et\u00a0al (2003) Assessment of adapalene gel for thetreatment of actinic keratoses and lentigines: a\u00a0randomizedtrial. J\u00a0Am Acad Dermatol 49:83\u201390","journal-title":"J Am Acad Dermatol"},{"key":"4715_CR17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00006534-200003000-00040","volume":"105","author":"K Yoshimura","year":"2000","unstructured":"Yoshimura\u00a0K, Harii\u00a0K, Aoyama\u00a0T, Iga\u00a0T (2000) Experience with astrong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 105:1097\u20131108","journal-title":"Plast Reconstr Surg"},{"key":"4715_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(00)90219-6","volume":"42","author":"AB Fleischer Jr","year":"2000","unstructured":"Fleischer\u00a0AB Jr, Schwartzel\u00a0EH, Colby\u00a0SI, Altman\u00a0DJ (2000) The combination of 2%4-hydroxyanisole (mequinol) and 0.01\u202f% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J\u00a0Am Acad Dermatol 42:459\u2013467","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"4715_CR19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/ijd.14497","volume":"58","author":"M Kheradmand","year":"2019","unstructured":"Kheradmand\u00a0M, Afshari\u00a0M, Damiani\u00a0G, Abediankenari\u00a0S, Moosazadeh\u00a0M (2019) Melasma and thyroid disorders: a\u00a0systematic review and meta-analysis. Int J Dermatol 58(11):1231\u20131212","journal-title":"Int J Dermatol"},{"key":"4715_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MOP.0b013e3283483ee8","volume":"23","author":"TS Wright","year":"2011","unstructured":"Wright\u00a0TS (2011) Cutaneous manifestations of malignancy. Curr Opin Pediatr 23:407\u2013411","journal-title":"Curr Opin Pediatr"},{"key":"4715_CR21","first-page":"196","volume-title":"Rook\u2019s textbook of dermatology","author":"N van Geel","year":"2016","unstructured":"van Geel\u00a0N, Speeckaert\u00a0R (2016) Acquired pigmentary disorders. In: Griffiths\u00a0C, Barker\u00a0J, Bleiker\u00a0T, Chalmers\u00a0R, Creamer\u00a0D (Hrsg) Rook\u2019s textbook of dermatology, S\u00a0196\u2013198"},{"key":"4715_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","volume":"152","author":"HK Bell","year":"2005","unstructured":"Bell\u00a0HK, Poston\u00a0GJ, Vora\u00a0J, Wilson\u00a0NJ (2005) Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol 152:71","journal-title":"Br J Dermatol"},{"key":"4715_CR23","first-page":"200","volume-title":"Rook\u2019s textbook of dermatology","author":"N van Geel","year":"2016","unstructured":"van Geel\u00a0N, Speeckaert\u00a0R (2016) Acquired pigmentary disorders. In: Griffiths\u00a0C, Barker\u00a0J, Bleiker\u00a0T, Chalmers\u00a0R, Creamer\u00a0D (Hrsg) Rook\u2019s textbook of dermatology, S\u00a0200\u2013201"},{"key":"4715_CR24","first-page":"236","volume-title":"Rook\u2019s textbook of dermatology","author":"N van Geel","year":"2016","unstructured":"van Geel\u00a0N, Speeckaert\u00a0R (2016) Acquired pigmentary disorders. In: Griffiths\u00a0C, Barker\u00a0J, Bleiker\u00a0T, Chalmers\u00a0R, Creamer\u00a0D (Hrsg) Rook\u2019s textbook of dermatology, S\u00a0236\u2013237"},{"issue":"3","key":"4715_CR25","first-page":"145","volume":"93","author":"K Fields","year":"2014","unstructured":"Fields\u00a0K, Milikowski\u00a0C, Jewell\u00a0T, Fields\u00a0J (2014) Localized diffuse melanosis associated with melanoma successfully treated with imiquimod cream 5\u202f%: a\u00a0case report and review of the literature. Cutis 93(3):145\u2013150","journal-title":"Cutis"},{"issue":"5","key":"4715_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/abd1806-4841.20175544","volume":"92","author":"Y-Y Lu","year":"2017","unstructured":"Lu\u00a0Y\u2011Y (2017) Hyperpigmentation as a\u00a0peculiar presentation of mycosis fungoides. An Bras Dermatol 92(5):92\u201394","journal-title":"An Bras Dermatol"},{"issue":"7","key":"4715_CR27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1468-3083.2006.02058.x","volume":"21","author":"H Erbil","year":"2007","unstructured":"Erbil\u00a0H, Sezer\u00a0E, Koseoglu\u00a0D, Filiz\u00a0N, Kurumlu\u00a0Z, Ta\u015ftan\u00a0HB, Demiriz\u00a0M (2007) Hyperpigmented mycosis fungoides: a\u00a0case report. J\u00a0Eur Acad Dermatol Venereol 21(7):982\u2013983","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4715_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13256-015-0697-2","volume":"9","author":"M Chuamanochan","year":"2015","unstructured":"Chuamanochan\u00a0M, Haws\u00a0AL, Pattanaprichaku\u00a0P (2015) Reticulate hyperpigmentation in systemic sclerosis: a\u00a0case report and review of the literature. J\u00a0Med Case Rep 9:21","journal-title":"J Med Case Rep"},{"issue":"4","key":"4715_CR29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","volume":"153","author":"M Dytoc","year":"2005","unstructured":"Dytoc\u00a0M, Ting\u00a0PT, Man\u00a0J, Sawyer\u00a0D, Fiorillo\u00a0L (2005) First case series on the use of imiquimod for morphoea. Br J Dermatol 153(4):815\u2013820","journal-title":"Br J Dermatol"},{"key":"4715_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13256-018-1618-y","volume":"12","author":"HMMTB Herath","year":"2018","unstructured":"Herath\u00a0HMMTB (2018) Erythroderma and extensive poikiloderma\u2014a\u00a0rare initial presentation of dermatomyositis: a\u00a0case report. J\u00a0Med Case Rep 12:83","journal-title":"J Med Case Rep"},{"issue":"2","key":"4715_CR31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaad.2020.03.123","volume":"83","author":"A Creadore","year":"2020","unstructured":"Creadore\u00a0A, Watchmaker\u00a0J, Maymone\u00a0MBC, Pappas\u00a0L, Vashi\u00a0NA, Lam\u00a0C (2020) Cosmetic treatment in patients with autoimmune connective tissue diseases best practices for patients with lupus erythematosus. J\u00a0Am Acad Dermatol 83(2):343\u2013363","journal-title":"J Am Acad Dermatol"},{"key":"4715_CR32","first-page":"339","volume":"9","author":"MA Shafiee","year":"2015","unstructured":"Shafiee\u00a0MA, Akbarian\u00a0F, Memon\u00a0KK, Aarabi\u00a0M, Boroumand\u00a0B (2015) Dermatologic manifestations in end-stage renal disease. Iran J Kidney Dis 9:339\u2013353","journal-title":"Iran J Kidney Dis"},{"key":"4715_CR33","first-page":"151","volume":"40","author":"AS Karadag","year":"2010","unstructured":"Karadag\u00a0AS, Simsek\u00a0GG (2010) Familial amyloidosis cutis dyschromica. Turk J Med Sci 40:151\u2013154","journal-title":"Turk J Med Sci"},{"key":"4715_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1750-1172-7-95","volume":"7","author":"J Qiao","year":"2012","unstructured":"Qiao\u00a0J, Fang\u00a0H, Hongtian\u00a0Y (2012) Amyloidosis cutis dyschromica. Orphanet J Rare Dis 7:95","journal-title":"Orphanet J Rare Dis"},{"key":"4715_CR35","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.4081\/dr.2014.5375","volume":"6","author":"M Hermawan","year":"2014","unstructured":"Hermawan\u00a0M, Rihatmadja\u00a0R, Sirait\u00a0SP (2014) Familial amyloidosis cutis dyschromica in three siblings: report from Indonesia. Dermatol Reports 6:5375","journal-title":"Dermatol Reports"},{"issue":"8","key":"4715_CR36","doi-asserted-by":"crossref","first-page":"13030\/qt38f676n","DOI":"10.5070\/D3238036004","volume":"23","author":"T Garg","year":"2017","unstructured":"Garg\u00a0T, Marak\u00a0A, Ahmed\u00a0R, Chander\u00a0R, Jain\u00a0M (2017) An unusual presentation of primary cutaneous amyloidosis. Dermatol Online\u00a0J 23(8):13030\/qt38f676n9","journal-title":"Dermatol Online J"},{"issue":"8","key":"4715_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","volume":"92","author":"A Dispenzieri","year":"2017","unstructured":"Dispenzieri\u00a0A (2017) POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92(8):814\u2013829","journal-title":"Am J Hematol"},{"issue":"11","key":"4715_CR38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-4632.2012.05648.x","volume":"52","author":"RYN Miest","year":"2013","unstructured":"Miest\u00a0RYN, Comfere\u00a0NI, Dispenzier\u00a0A (2013) Cutaneous manifestations in patients with POEMS syndrome. Int J Dermatol 52(11):1349\u20131356","journal-title":"Int J Dermatol"},{"issue":"10","key":"4715_CR39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1524-4725.2011.02083.x","volume":"37","author":"S Bagheri","year":"2011","unstructured":"Bagheri\u00a0S, Eisen\u00a0D (2011) Long-pulse neodymium-doped yttrium aluminum garnet laser treatment improves amiodarone-induced hyperpigmentation. Dermatol Surg 37(10):1539\u20131541","journal-title":"Dermatol Surg"},{"key":"4715_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2000.105506","volume":"43","author":"DH Atkin","year":"2000","unstructured":"Atkin\u00a0DH, Fitzpatrick\u00a0RE (2000) Laser treatment of imipramine-induced hyperpigmentation. J\u00a0Am Acad Dermatol 43:77\u201380","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"4715_CR41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/DSS.0000000000000455","volume":"41","author":"M Rodrigues","year":"2015","unstructured":"Rodrigues\u00a0M, Bekhor\u00a0P (2015) Treatment of minocycline induced cutaneous pigmentation with the picosecond alexandrite (755-nm) laser. Dermatol Surg 41(10):1179\u20131182","journal-title":"Dermatol Surg"},{"key":"4715_CR42","first-page":"159","volume":"6","author":"M Nisar","year":"2013","unstructured":"Nisar\u00a0M, Iyer\u00a0K, Brodell\u00a0R et al (2013) Minocycline-induced hyperpigmentation: a\u00a0comparison of 3 Q\u2011switched lasers to reverse its effects. Clin Cosmet Investig Dermatol 6:159\u2013162","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"4715_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-020-00505-3","volume":"21","author":"AM John","year":"2020","unstructured":"John\u00a0AM, Handler\u00a0MZ, Schwartz\u00a0RA (2020) Fixed drug eruptions: an update, emphasizing the potentially lethal generalized bullous fixed drug eruption. Am J Clin Dermatol 21(3):393\u2013399","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"4715_CR44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2004.02267.x","volume":"43","author":"NL Lacz","year":"2004","unstructured":"Lacz\u00a0NL, Vafaie\u00a0J, Kihiczak\u00a0NI, Schwartz\u00a0RA (2004) Postinflammatory hyperpigmentation: a\u00a0common but troubling condition. Int J Dermatol 43(5):362\u2013365","journal-title":"Int J Dermatol"},{"issue":"4","key":"4715_CR45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2017.01.036","volume":"77","author":"S Chaowattanapanit","year":"2017","unstructured":"Chaowattanapanit\u00a0S, Silpa-Archa\u00a0N, Kohli\u00a0I, Lim\u00a0HW, Hamzav\u00a0I (2017) Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J\u00a0Am Acad Dermatol 77(4):607\u2013621","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4715_CR46","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis\u00a0EC, Callender\u00a0VD (2010) Postinflammatory hyperpigmentation - a review of the epidemiology, clinical features, and treatment options in skin of color. J\u00a0Clin Aesthet Dermatol 3(7):20\u201331","journal-title":"J Clin Aesthet Dermatol"},{"key":"4715_CR47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-4632.2008.03625.x","volume":"47","author":"S Zaynoun","year":"2008","unstructured":"Zaynoun\u00a0S, Rubeiz\u00a0N, Kibbi\u00a0A\u2011G (2008) Ashy dermatoses: a\u00a0critical review of the literature and a\u00a0proposed simplified clinical classification. Int J Dermatol 47:542\u2013544","journal-title":"Int J Dermatol"},{"issue":"3","key":"4715_CR48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-4632.2004.02001.x","volume":"43","author":"RA Schwartz","year":"2004","unstructured":"Schwartz\u00a0RA (2004) Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol 43(3):230\u2013232","journal-title":"Int J Dermatol"},{"issue":"5","key":"4715_CR49","doi-asserted-by":"crossref","first-page":"13030\/qt44f462s","DOI":"10.5070\/D3255044058","volume":"25","author":"K Nguyen","year":"2019","unstructured":"Nguyen\u00a0K, Khachemoune\u00a0A (2019) Ashy dermatosis: a\u00a0review. Dermatol Online\u00a0J 25(5):13030\/qt44f462s8","journal-title":"Dermatol Online J"},{"issue":"5","key":"4715_CR50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/0019-5154.164452","volume":"60","author":"VK Mahajan","year":"2015","unstructured":"Mahajan\u00a0VK, Chauhan\u00a0PS, Mehta\u00a0KS, Sharma\u00a0AL (2015) Erythema dyschromicum perstans: response to topical tacrolimus. Indian J Dermatol 60(5):525","journal-title":"Indian J Dermatol"},{"issue":"3","key":"4715_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdcr.2019.12.015","volume":"6","author":"A Diaz","year":"2020","unstructured":"Diaz\u00a0A, Gillihan\u00a0R, Motaparthi\u00a0K, Rees\u00a0A (2020) Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: a retrospective series. JAAD Case Rep 6(3):207\u2013213","journal-title":"JAAD Case Rep"},{"key":"4715_CR52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/09546634.2011.565016","volume":"23","author":"MW Kroon","year":"2012","unstructured":"Kroon\u00a0MW, Wind\u00a0BS, Meesters\u00a0AA et al (2012) Non-ablative 1550\u202fnm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a\u00a0pilot study. J\u00a0Dermatolog Treat 23:339\u2013344","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"4715_CR53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/lsm.22567","volume":"49","author":"JA Wolfshohl","year":"2017","unstructured":"Wolfshohl\u00a0JA, Geddes\u00a0ERC, Stout\u00a0AB, Friedman\u00a0PM (2017) Improvement of erythema dyschromicum perstans using a\u00a0combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment. Lasers Surg Med 49(1):60\u201362","journal-title":"Lasers Surg Med"},{"key":"4715_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546634.2020.1793892","volume":"20","author":"PN Madu","year":"2020","unstructured":"Madu\u00a0PN, Syder\u00a0N, Elbuluk\u00a0N (2020) Postinflammatory hypopigmentation: a\u00a0comprehensive review of treatments. J\u00a0Dermatolog Treat 20:1\u20135","journal-title":"J Dermatolog Treat"},{"key":"4715_CR55","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaad.2006.03.020","volume":"55","author":"GN Relyveld","year":"2006","unstructured":"Relyveld\u00a0GN, Kingswijk\u00a0MM, Reitsma\u00a0JB et\u00a0al (2006) Benzoyl peroxide\/clindamycin\/ UVA is more effective than fluticasone\/UVA in progressive macular hypomelanosis: a\u00a0randomized study. J\u00a0Am Acad Dermatol 55:836\u2013843","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4715_CR56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-0781.2011.00583.x","volume":"27","author":"L Cuesta Montero","year":"2011","unstructured":"Cuesta Montero\u00a0L, Belinch\u00f3n\u00a0I, Toledo\u00a0F, Betlloch\u00a0I (2011) Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 27(3):162\u2013163","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"4715_CR57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1590\/abd1806-4841.20164972","volume":"91","author":"MV Gozali","year":"2016","unstructured":"Gozali\u00a0MV, Zhang\u00a0J, Yi\u00a0F, Zhou\u00a0B, Luo\u00a0D (2016) Chemical leukoderma induced by dimethyl sulfate. An Bras Dermatol 91(5):26\u201328","journal-title":"An Bras Dermatol"},{"issue":"3","key":"4715_CR58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/DER.0000000000000167","volume":"27","author":"D Bonamonte","year":"2016","unstructured":"Bonamonte\u00a0D, Vestita\u00a0M, Romita\u00a0P, Filoni\u00a0A, Fot\u00a0C, Angelini\u00a0G (2016) Chemical leukoderma. Dermatitis 27(3):90\u201399","journal-title":"Dermatitis"},{"key":"4715_CR59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5021\/ad.2010.22.2.241","volume":"22","author":"JY Jung","year":"2010","unstructured":"Jung\u00a0JY, Yeom\u00a0KB, Eun\u00a0HC (2010) Chemical leukoderma improved by low-dose steroid pulse therapy. Ann Dermatol 22:241\u2013244","journal-title":"Ann Dermatol"},{"key":"4715_CR60","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/j.1468-3083.2012.04597.x","volume":"27","author":"J Shin","year":"2013","unstructured":"Shin\u00a0J, Kim\u00a0M, Park\u00a0SH, Oh\u00a0SH (2013) The effect of fractional carbon dioxide lasers on idiopathic guttate hypomelanosis: a\u00a0preliminary study. J\u00a0Eur Acad Dermatol Venereol 27:e243\u20136","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"4715_CR61","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/jdv.12763","volume":"29","author":"P Rerknimitr","year":"2015","unstructured":"Rerknimitr\u00a0P, Chitvanich\u00a0S, Pongprutthipan\u00a0M, Panchaprateep\u00a0R, Asawanonda\u00a0P (2015) Non-ablative fractional photothermolysis in treatment of idiopathic guttate hypomelanosis. J\u00a0Eur Acad Dermatol Venereol 29(11):2238\u20132242","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4715_CR62","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1468-3083.2012.04462.x","volume":"27","author":"P Rerknimitr","year":"2013","unstructured":"Rerknimitr\u00a0P, Disphanurat\u00a0W, Achariyakul\u00a0M (2013) Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a\u00a0double-blind, randomized, placebo-controlled study. J\u00a0Eur Acad Dermatol Venereol 27:460\u2013464","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"4715_CR63","first-page":"238","volume":"9","author":"P Asawanonda","year":"2010","unstructured":"Asawanonda\u00a0P, Sutthipong\u00a0T, Prejawai\u00a0N (2010) Pimecrolimus for idiopathic guttate hypomelanosis. J\u00a0Drugs Dermatol 9(3):238\u2013239","journal-title":"J Drugs Dermatol"},{"key":"4715_CR64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1346-8138.2004.tb00701.x","volume":"31","author":"SP Kumarasinghe","year":"2004","unstructured":"Kumarasinghe\u00a0SP (2004) 3\u20135 second cryotherapy is effective in idiopathic guttate hypomelanosis. J\u00a0Dermatol 31:437\u2013439","journal-title":"J Dermatol"},{"issue":"1 Pt 1","key":"4715_CR65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0190-9622(87)70003-6","volume":"16","author":"R Falabella","year":"1987","unstructured":"Falabella\u00a0R, Escobar\u00a0C, Giraldo\u00a0N, Rovetto\u00a0P, Gil\u00a0J, Barona\u00a0MI et\u00a0al (1987) On the pathogenesis of idiopathic guttate hypomelanosis. J\u00a0Am Acad Dermatol 16(1 Pt 1):35\u201344","journal-title":"J Am Acad Dermatol"},{"key":"4715_CR66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/000155599750010724","volume":"79","author":"AK Pagnoni","year":"1999","unstructured":"Pagnoni\u00a0AK, Sadiq\u00a0I, Stoudemayer\u00a0T (1999) Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol 79:305\u2013310","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"4715_CR67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/2229-5178.126021","volume":"5","author":"SP Ravikiran","year":"2014","unstructured":"Ravikiran\u00a0SP, Sacchidanand\u00a0S, Leelavathy\u00a0B (2014) Therapeutic wounding: 88\u202f% phenol in idiopathic guttate hypomelanosis. Indian Dermatol Online\u00a0J 5(1):14\u201318","journal-title":"Indian Dermatol Online J"},{"issue":"11","key":"4715_CR68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1524-4725.1999.99186-8.x","volume":"25","author":"DM Hexsel","year":"1999","unstructured":"Hexsel\u00a0DM (1999) Treatment of idiopathic guttate hypomelanosis by localized superficial dermabrasion. Dermatol Surg 25(11):917\u2013918","journal-title":"Dermatol Surg"},{"issue":"5","key":"4715_CR69","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5021\/ad.2017.29.5.630","volume":"29","author":"HM Jung","year":"2017","unstructured":"Jung\u00a0HM, Kim\u00a0H, Lee\u00a0JH, Gyong Moon\u00a0K, Bae\u00a0JM (2017) Treatment of laser therapy-induced punctate leukoderma using a\u00a0308-nm excimer laser. Ann Dermatol 29(5):630\u2013632","journal-title":"Ann Dermatol"},{"key":"4715_CR70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1524-4725.2012.02397.x","volume":"38","author":"HS Kim","year":"2012","unstructured":"Kim\u00a0HS, Jung\u00a0HD, Kim\u00a0HO, Lee\u00a0JY, Park\u00a0YM (2012) Punctate leucoderma after low-fluence 1,064-nm quality-switched neodymium-doped yttrium aluminum garnet laser therapy successfully managed using a\u00a0308-nm excimer laser. Dermatol Surg 38:821\u2013823","journal-title":"Dermatol Surg"},{"issue":"11","key":"4715_CR71","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/jdv.15699","volume":"33","author":"K Fong","year":"2019","unstructured":"Fong\u00a0K, Goh\u00a0BK (2019) Epidermal cellular grafting as a\u00a0treatment for punctate leukoderma secondary to laser toning. J\u00a0Eur Acad Dermatol Venereol 33(11):e396\u2013e397","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"4715_CR72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamadermatol.2013.234","volume":"149","author":"SP Gottesman","year":"2013","unstructured":"Gottesman\u00a0SP, Goldberg\u00a0GN (2013) Immediate successful treatment of argyria with a\u00a0single pass of multiple Q\u2011switched laser wavelengths. JAMA Dermatol 149(5):623\u2013624","journal-title":"JAMA Dermatol"},{"issue":"11","key":"4715_CR73","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/jdv.13117","volume":"29","author":"RD Griffith","year":"2015","unstructured":"Griffith\u00a0RD, Simmons\u00a0BJ, Bray\u00a0FN, Falto-Aizpurua\u00a0LA, Yazdani Abyaneh\u00a0MA, Nouri\u00a0K (2015) 1064\u202fnm Q\u2011switched Nd:YAG laser for the treatment of argyria: a\u00a0systematic review. J\u00a0Eur Acad Dermatol Venereol 29(11):2100\u20132103","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"4715_CR74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-4632.2010.04796.x","volume":"50","author":"TY Han","year":"2011","unstructured":"Han\u00a0TY, Chang\u00a0HS, Lee\u00a0HK, Son\u00a0SJ (2011) Successful treatment of argyria using a\u00a0low-fluence Q\u2011switched 1064-nm Nd:YAG laser. Int J Dermatol 50(6):751\u2013753","journal-title":"Int J Dermatol"},{"issue":"8","key":"4715_CR75","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/DSS.0000000000001162","volume":"43","author":"DP Friedmann","year":"2017","unstructured":"Friedmann\u00a0DP, Buckley\u00a0S, Mishra\u00a0V (2017) Localized cutaneous argyria from a\u00a0nasal piercing successfully treated with a\u00a0picosecond 755-nm Q\u2011switched alexandrite laser. Dermatol Surg 43(8):1094\u20131095","journal-title":"Dermatol Surg"},{"issue":"1-3","key":"4715_CR76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-4274(01)00534-3","volume":"128","author":"AH Hall","year":"2002","unstructured":"Hall\u00a0AH (2002) Chronic arsenic poisoning. Toxicol Lett 128(1-3):69\u201372","journal-title":"Toxicol Lett"},{"issue":"3","key":"4715_CR77","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1524-4725.2009.01092.x","volume":"35","author":"JJ Wu","year":"2009","unstructured":"Wu\u00a0JJ, Papajohn\u00a0NG, Murase\u00a0JE, Verkruysse\u00a0W, Kelly\u00a0KM (2009) Generalized chrysiasis improved with pulsed dye laser. Dermatol Surg 35(3):538\u2013542","journal-title":"Dermatol Surg"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04715-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04715-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T14:29:47Z","timestamp":1697120987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04715-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04715-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"17 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Danescu, C.\u00a0Salavastru, G.\u00a0Tiplica und K.\u00a0Fritz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}